Tianjin Lisheng Pharmaceutical Co.,Ltd.
Символ: 002393.SZ
SHZ
24.45
CNYПазарна цена днес
12.5136
Съотношение P/E
0.0095
Коефициент PEG
4.46B
MRK Cap
- 0.01%
Доходност на DIV
Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393-SZ) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 8190.43 | 2220.2 | 1993.6 | 1651.9 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 138.49 | 231.3 | 200.3 | -31.9 | ||||||||||||||||||
balance-sheet.row.net-receivables | 1945.69 | 321.5 | 427.7 | 461.9 | ||||||||||||||||||
balance-sheet.row.inventory | 793.34 | 176.3 | 199.1 | 228.8 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 263.38 | 100.5 | 4.9 | 13.9 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 11192.83 | 2818.5 | 2625.4 | 2356.4 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 4028.67 | 981.9 | 1029.8 | 1136.7 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 517.83 | 124.9 | 135.5 | 144.2 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 517.83 | 124.9 | 135.5 | 144.2 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 5960.03 | 1810.6 | 1180.6 | 1531.8 | ||||||||||||||||||
balance-sheet.row.tax-assets | 128.84 | 39.5 | 33.7 | 16.3 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 165.52 | 5.3 | 286.1 | 5.5 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 10800.9 | 2962.1 | 2665.6 | 2834.5 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 21993.73 | 5780.6 | 5291 | 5190.9 | ||||||||||||||||||
balance-sheet.row.account-payables | 338.78 | 84.8 | 146.4 | 90.5 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 221.03 | 59.1 | 39.7 | 28.5 | ||||||||||||||||||
balance-sheet.row.tax-payables | 115.85 | 14.6 | 42.5 | 20.3 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 19.2 | 3.9 | 5.4 | 6.2 | ||||||||||||||||||
Deferred Revenue Non Current | 121.79 | 27.9 | 31.8 | 31.7 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 690.03 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 1023.39 | 467.4 | 543.9 | 1.4 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 857.62 | 223 | 211.7 | 228 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 19.2 | 3.9 | 5.4 | 6.2 | ||||||||||||||||||
balance-sheet.row.total-liab | 3616.86 | 849.2 | 941.7 | 780.4 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 736.26 | 184.3 | 184 | 182.5 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 5159.76 | 1393.7 | 1126.6 | 1098 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 9115.58 | 1612 | 1328.7 | 1439.4 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3337.33 | 1713.4 | 1710.1 | 1690.7 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 18348.93 | 4903.4 | 4349.4 | 4410.5 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 21993.73 | 5780.6 | 5291 | 5190.9 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-equity | 18348.93 | 4903.4 | 4349.4 | 4410.5 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 21993.73 | - | - | - | ||||||||||||||||||
Total Investments | 6098.52 | 2041.9 | 1380.9 | 1499.8 | ||||||||||||||||||
balance-sheet.row.total-debt | 240.23 | 63 | 45.1 | 34.7 | ||||||||||||||||||
balance-sheet.row.net-debt | -7718.94 | -1925.9 | -1748.2 | -1617.2 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 361.83 | 361.8 | 93.6 | 122.1 | ||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 16.99 | 67.3 | 66.1 | 60.2 | ||||||||||||||||||
cash-flows.row.deferred-income-tax | -36.38 | -5.5 | -15.4 | -8.7 | ||||||||||||||||||
cash-flows.row.stock-based-compensation | 6.11 | -136.5 | 15.4 | 8.7 | ||||||||||||||||||
cash-flows.row.change-in-working-capital | 29.92 | 1.6 | 137.9 | 17.6 | ||||||||||||||||||
cash-flows.row.account-receivables | 17.52 | 17.5 | 25.1 | -19.5 | ||||||||||||||||||
cash-flows.row.inventory | 8.91 | 8.9 | 11.1 | -4.4 | ||||||||||||||||||
cash-flows.row.account-payables | 0 | -28.3 | 117 | 50.2 | ||||||||||||||||||
cash-flows.row.other-working-capital | 3.49 | 3.5 | -15.4 | -8.7 | ||||||||||||||||||
cash-flows.row.other-non-cash-items | -179.99 | -79.3 | 33.8 | -3.6 | ||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 198.48 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -61.72 | -61.7 | -40.9 | -88.2 | ||||||||||||||||||
cash-flows.row.acquisitions-net | 151.54 | 151.5 | 115.3 | 0.1 | ||||||||||||||||||
cash-flows.row.purchases-of-investments | -470 | -470 | -320 | -70 | ||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 398.8 | 390 | 90 | 82 | ||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 18.62 | 9.9 | -155.6 | -76.1 | ||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -0.1 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.dividends-paid | -110.49 | -54.7 | -54.7 | -18.2 | ||||||||||||||||||
cash-flows.row.other-financing-activites | 5.91 | 5.9 | 21 | 0 | ||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -48.82 | -48.8 | -33.8 | -18.2 | ||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 30.37 | 25.1 | 0 | 0 | ||||||||||||||||||
cash-flows.row.net-change-in-cash | 209.67 | 195.7 | 142 | 102 | ||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 7908.62 | 1989 | 1769.6 | 1627.7 | ||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 7698.95 | 1793.3 | 1627.7 | 1525.7 | ||||||||||||||||||
cash-flows.row.operating-cash-flow | 198.48 | 209.5 | 331.4 | 196.3 | ||||||||||||||||||
cash-flows.row.capital-expenditure | -61.72 | -61.7 | -40.9 | -88.2 | ||||||||||||||||||
cash-flows.row.free-cash-flow | 136.76 | 147.8 | 290.5 | 108.1 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1147.43 | 1130.2 | 1146.6 | 1091.9 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 474.87 | 495.6 | 486.3 | 454.5 | ||||||||||||||||||
income-statement-row.row.gross-profit | 672.56 | 634.5 | 660.3 | 637.5 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 102.82 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 24.61 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 318.94 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | -23.88 | -13.8 | 108.4 | 96.1 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 573.75 | 521.9 | 576.8 | 591.8 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 1048.62 | 1017.5 | 1063.1 | 1046.3 | ||||||||||||||||||
income-statement-row.row.interest-income | -13.97 | 61.2 | 68.3 | 87.6 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0.75 | 0.9 | 0.9 | 0.3 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 318.94 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 30.84 | 296.6 | -57.3 | 0.2 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | -23.88 | -13.8 | 108.4 | 96.1 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 30.84 | 296.6 | -57.3 | 0.2 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0.75 | 0.9 | 0.9 | 0.3 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | -220.55 | 67.3 | 66.1 | 75.8 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 166.47 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 387.01 | 112.6 | 175.7 | 136.9 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 417.85 | 409.2 | 118.4 | 137.1 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 58.39 | 58.4 | 24.8 | 15 | ||||||||||||||||||
income-statement-row.row.net-income | 361.83 | 361.8 | 93.6 | 122.1 |
Често задавани въпроси
Какво е Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) общи активи?
Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) общите активи са 5780604152.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 489934126.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.735.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.735.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.315.
Какъв е общият приход на предприятието?
Общият приход е 0.337.
Каква е Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 361827990.000.
Какъв е общият дълг на фирмата?
Общият дълг е 63035414.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 521915434.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 1988965076.000.